Skip to content

RestoreX 117Recalls & reported problems

Pathright Medical Inc. · RestoreX Kit - penile traction therapy device for the treatment of Peyronie's disease. Contains RestoreX device, extension rods, self-adherent wrap, Instructions for Use · Class 1

Adverse event reports
2
Deaths reported
0
Injuries reported
1
Recalls naming it
0

Summary

The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00860001453805), received between May 15, 2026 and May 15, 2026 — classified as 1 injury, 1 malfunction.

The most frequently reported specific device problem is “Use of Device Problem” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 2 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Use of Device Problem1
  • Use of Incorrect Control/Treatment Settings1

Patient problems

  • Erectile Dysfunction1
  • Hypoesthesia1
  • Pain1
  • Tissue Irritation1
  • Unspecified Tissue Injury1
  • Urinary Incontinence1

Recent adverse event reports

The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.

  • InjuryMay 15, 2026Use of Incorrect Control/Treatment Settings

    CUSTOMER REPORTED THAT USE OF THE RESTOREX DEVICE RESULTED IN A TEAR IN THE CORPUS SPONGIOSUM, WORSENING ERECTILE FUNCTION, URINARY INCONTINENCE, AND ONGOING PAIN AND INFLAMMATION. THE CUSTOMER STATED THE DEVICE WAS USED ACCORDING TO INSTRUCTIONS, INCLUDING USE AT MAXIMUM TENSION SETTINGS OVER AN EXTENDED PERIOD. PATHRIGHT REQUESTED SUPPORTING MEDICAL RECORDS AND IMAGES TO EVALUATE THE ALLEGATIONS; HOWEVER, NO DOCUMENTATION WAS PROVIDED. BASED ON AVAILABLE INFORMATION AND INTERNAL REVIEW, THE REPORTED INJURIES WERE NOT VERIFIED, AND NO CAUSAL RELATIONSHIP TO THE DEVICE COULD BE ESTABLISHED.

    Patient problems: Pain; Tissue Irritation; Unspecified Tissue Injury; Urinary Incontinence

    MAUDE report 25191794 ↗
  • MalfunctionMay 15, 2026Use of Device Problem

    PATIENT REPORTED USING THE DEVICE APPROXIMATELY 5 HOURS PER DAY, EXCEEDING THE INSTRUCTIONS FOR USE WHICH STATE NOT TO USE THE DEVICE FOR MORE THAN 1 HOUR PER DAY OR MORE THAN 30 MINUTES AT A TIME AND TO SEPARATE SESSIONS BY AT LEAST 30 MINUTES. THE PATIENT ALSO REPORTED TIGHTENING THE CLAMP BEYOND NORMAL USE AND APPLYING MAXIMUM TENSION, SOMETIMES MANUALLY INCREASING FORCE. THE PATIENT REPORTED DECREASED PENILE SENSITIVITY AND WEAKER ERECTIONS. ON (B)(6) 2023 THE PATIENT WAS EVALUATED BY A UROLOGIST AND UNDERWENT A PENILE ULTRASOUND ON (B)(6) 2023. THE PATIENT REPORTED THAT THE ULTRASOUND SHOWED NUMERICAL FINDINGS SUGGESTIVE OF A POSSIBLE VENOUS LEAK. NO SURGICAL INTERVENTION OR HOSPITALIZATION WAS REPORTED. THE PATIENT WAS ADVISED TO DISCONTINUE USE. FOLLOW UP COMMUNICATION MONTHS LATER INDICATED THAT THE PATIENT REPORTED HIS CONDITION HAD RETURNED TO NORMAL. NO DEVICE MALFUNCTION WAS REPORTED.

    Patient problems: Erectile Dysfunction; Hypoesthesia

    MAUDE report 25191793 ↗

Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.